1887

Journal of General Virology header logo

Volume 82, Issue 2

The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus Free

Abstract

In addition to the RI (replicative intermediate RNA) and native RF (replicative form RNA), mouse hepatitis virus-infected cells contained six species of RNA intermediates active in transcribing subgenomic mRNA. We have named these transcriptive intermediates (TIs) and native transcriptive forms (TFs) because they are not replicating genome-sized RNA. Based on solubility in high salt solutions, approximately 70% of the replicating and transcribing structures that accumulated in infected cells by 5–6 h post-infection were multi-stranded intermediates, the RI/TIs. The other 30% were in double-stranded structures, the native RF/TFs. These replicating and transcribing structures were separated by velocity sedimentation on sucrose gradients or by gel filtration chromatography on Sepharose 2B and Sephacryl S-1000, and migrated on agarose gels during electrophoresis, according to their size. Digestion with RNase T1 at 1–10 units/μg RNA resolved RI/TIs into RF/TF cores and left native RF/TFs intact, whereas RNase A at concentrations of 0·02 μg/μg RNA or higher degraded both native RF/TFs and RI/TIs. Viral RI/TIs and native RF/TFs bound to magnetic beads containing oligo(dT), suggesting that the poly(A) sequence on the 3′ end of the positive strands was longer than any poly(U) on the negative strands. Kinetics of incorporation of [H]uridine showed that both the RI and TIs were transcriptionally active and the labelling of RI/TIs was not the dead-end product of aberrant negative-strand synthesis. Failure originally to find TIs and TF cores was probably due to overdigestion with RNase A.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-2-385
2001-02-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/2/0820385a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-2-385&mimeType=html&fmt=ahah

References

  1. Almazan F., Gonzalez J. M., Penzes Z., Izeta A., Calvo E., Plana-Duran J., Enjuanes L. 2000; Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proceedings of the National Academy of Sciences, USA 97:5516–5521
     [Google Scholar]
  2. Ammann J., Delius H., Hofschneider P. H. 1964; Isolation and properties of an intact phage-specific replicative form of RNA phage M12. Journal of Molecular Biology 10:557–561
     [Google Scholar]
  3. An S., Maeda A., Makino S. 1998; Coronavirus transcription early in infection. Journal of Virology 72:8517–8524
     [Google Scholar]
  4. Baltimore D. 1966; Purification and properties of the poliovirus double-stranded ribonucleic acid. Journal of Molecular Biology 18:421–428
     [Google Scholar]
  5. Baltimore D. 1968; Structure of the poliovirus replicative intermediate RNA. Journal of Molecular Biology 32:359–368
     [Google Scholar]
  6. Baric R. S., Yount B. 2000; Subgenomic negative-strand RNA function during mouse hepatitis virus infection. Journal of Virology 74:4039–4046
     [Google Scholar]
  7. Baric R. S., Stohlman S. A., Lai M. M. 1983; Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. Journal of Virology 48:633–640
     [Google Scholar]
  8. Bishop J. M., Koch G. 1967; Purification and characterization of poliovirus induced infectious double-stranded RNA. Journal of Biological Chemistry 242:1736–1743
     [Google Scholar]
  9. Bishop J. M., Koch G., Evans G., Merriman M. 1969; Poliovirus replicative intermediate: structural basis of infectivity. Journal of Molecular Biology 46:235–249
     [Google Scholar]
  10. den Boon J. A., Kleijnen M. F., Spaan W. J., Snijder E. J. 1996; Equine arteritis virus subgenomic mRNA synthesis: analysis of leader–body junctions and replicative-form RNAs. Journal of Virology 70:4291–4298
     [Google Scholar]
  11. Erikson R. L., Gordon J. A. 1966; Replication of bacteriophage RNA: purification of the replicative intermediate by agarose gel chromatography. Biochemical and Biophysical Research Communications 23:422–428
     [Google Scholar]
  12. Fenwick M. L., Erikson R. L., Franklin R. M. 1964; Replication of the RNA of bacteriophage R17. Science 146:527–530
     [Google Scholar]
  13. Hofmann M. A., Brian D. A. 1991; The 5′ end of coronavirus minus-strand RNAs contains a short poly(U) tract. Journal of Virology 65:6331–6333
     [Google Scholar]
  14. Jeong Y. S., Makino S. 1994; Evidence for coronavirus discontinuous transcription. Journal of Virology 68:2615–2623
     [Google Scholar]
  15. Koch F. X., Koch G. 1985 The Molecular Biology of Poliovirus Vienna & New York: Springer-Verlag;
  16. Lai M. M., Patton C. D., Stohlman S. A. 1982a; Further characterization of mRNAs of mouse hepatitis virus: presence of common 5′-end nucleotides. Journal of Virology 41:557–565
     [Google Scholar]
  17. Lai M. M., Patton C. D., Stohlman S. A. 1982b; Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. Journal of Virology 44:487–492
     [Google Scholar]
  18. Lai M. M., Patton C. D., Baric R. S., Stohlman S. A. 1983; Presence of leader sequences in the mRNA of mouse hepatitis virus. Journal of Virology 46:1027–1033
     [Google Scholar]
  19. Masters P. S., Koetzner C. A., Kerr C. A., Heo Y. 1994; Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. Journal of Virology 68:328–337
     [Google Scholar]
  20. Montagnier L., Sanders F. 1963; Replicative form of encephalomyocarditis virus ribonucleic acid. Nature 199:664
     [Google Scholar]
  21. Richards O. C., Martin S. C., Jense H. G., Ehrenfeld E. 1984; Structure of poliovirus replicative intermediate RNA. Electron microscope analysis of RNA cross-linked in vivo with psoralen derivative. Journal of Molecular Biology 173:325–340
     [Google Scholar]
  22. Sawicki D. L., Gomatos P. J. 1976; Replication of Semliki Forest virus: polyadenylate in plus-strand RNA and polyuridylate in minus-strand RNA. Journal of Virology 20:446–464
     [Google Scholar]
  23. Sawicki S. G., Sawicki D. L. 1986a; Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis. Journal of Virology 57:328–334
     [Google Scholar]
  24. Sawicki S. G., Sawicki D. L. 1986b; The effect of loss of regulation of minus-strand RNA synthesis on Sindbis virus replication. Virology 151:339–349
     [Google Scholar]
  25. Sawicki S. G., Sawicki D. L. 1990; Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. Journal of Virology 64:1050–1056
     [Google Scholar]
  26. Sawicki S. G., Sawicki D. L. 1995; Coronaviruses use discontinuous extension for synthesis of subgenome-length negative strands. Advances in Experimental Medicine and Biology 380:499–506
     [Google Scholar]
  27. Sawicki D., Barkhimer D. B., Sawicki S. G., Rice C. M., Schlesinger S. 1990; Temperature sensitive shut-off of alphavirus minus strand RNA synthesis maps to a nonstructural protein, nsP4. Virology17443–52
     [Google Scholar]
  28. Schaad M. C., Baric R. S. 1994; Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates. Journal of Virology 68:8169–8179
     [Google Scholar]
  29. Sethna P. B., Hung S. L., Brian D. A. 1989; Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proceedings of the National Academy of Sciences, USA 86:5626–5630
     [Google Scholar]
  30. Sethna P. B., Hofmann M. A., Brian D. A. 1991; Minus-strand copies of replicating coronavirus mRNAs contain antileaders. Journal of Virology 65:320–325
     [Google Scholar]
  31. Snijder E. J., Meulenberg J. J. M. 1998; The molecular biology of arteriviruses. Journal of General Virology 79:961–979
     [Google Scholar]
  32. Spaan W., Cavanagh D., Horzinek M. C. 1988; Coronaviruses: structure and genome expression. Journal of General Virology 69:2939–2952
     [Google Scholar]
  33. Sturman L. S., Takemoto K. K. 1972; Enhanced growth of a murine coronavirus in transformed mouse cells. Infection and Immunity 6:501–507
     [Google Scholar]
  34. van Dinten L. C., den Boon J. A., Wassenaar A. L., Spaan W. J., Snijder E. J. 1997; An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proceedings of the National Academy of Sciences, USA 94:991–996
     [Google Scholar]
  35. van Dinten L. C., van Tol H., Gorbalenya A. E., Snijder E. J. 2000; The predicted metal-binding region of the arterivirus helicase protein is involved in subgenomic mRNA synthesis, genome replication, and virion biogenesis. Journal of Virology 74:5213–5223
     [Google Scholar]
  36. van Marle G., van Dinten L. C., Spaan W. J., Luytjes W., Snijder E. J. 1999; Characterization of an equine arteritis virus replicase mutant defective in subgenomic mRNA synthesis. Journal of Virology 73:5274–5281
     [Google Scholar]
  37. Yogo Y., Wimmer E. 1975; Sequence studies of poliovirus RNA. III. Polyuridylic acid and polyadenylic acid as components of the purified poliovirus replicative intermediate. Journal of Molecular Biology 92:467–477
     [Google Scholar]
  38. Yogo Y., Hirano N., Hino S., Shibuta H., Matumoto M. 1977; Polyadenylate in the virion RNA of mouse hepatitis virus. Journal of Biochemistry 82:1103–1108
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-2-385
Loading
The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus
J. Gen. Virol. 82, 385 (2001); https://doi.org/10.1099/0022-1317-82-2-385
/content/journal/jgv/10.1099/0022-1317-82-2-385
/content/journal/jgv/10.1099/0022-1317-82-2-385
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error